Skip to main content
. 2016 Jan 5;2016(1):CD002201. doi: 10.1002/14651858.CD002201.pub5

Hanssens 2015.

Methods 12‐month longitudinal randomised double‐blind placebo‐controlled trial.
Participants 16 people with CF, homozygous D508, over 5 years of age.
Interventions Randomised to placebo or oral supplement of omega 3, 60 mg/kg.
Outcomes Clinical and nutritional status; lung function; exercise tolerance.
Notes N = 13 completed, 6 intervention, 7 placebo. Supplement well‐tolerated.